Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 9, 2010, Pages

  Wu, Harry ^a   Nguyen, Geoffrey C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deep Venous Thrombosis; Hospitalization; Liver Cirrhosis; Venous Thromboembolism

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; FEMALE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RISK ASSESSMENT; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 77956172304     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.05.014     Document Type: Article

References (40)

1. Afdhal N., McHutchison J., Brown R., et al. Thrombocytopenia associated with chronic liver disease. J Hepatol 2008, 48:1000-1007.
2. Giannini E.G., Savarino V. Thrombocytopenia in liver disease. Curr Opin Hematol 2008, 15:473-480.
3. Amitrano L., Guardascione M.A., Brancaccio V., et al. Coagulation disorders in liver disease. Semin Liver Dis 2002, 22(01):83-96.
4. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1995, 346:1575-1582. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study.
5. Hoibraaten E., Qvigstad E., Arnesen H., et al. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled Estrogen in Venous Thromboembolism Trial (EVTET). Thromb Haemost 2000, 84:961-967.
6. Farmer R.D., Lawrenson R.A., Thompson C.R., et al. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997, 349:83-88.
7. De Besi L., Zucchetta P., Zotti S., et al. Sex hormones and sex hormone binding globulin in males with compensated and decompensated cirrhosis of the liver. Acta Endocrinol (Copenh) 1989, 120:271-276.
8. Kaymakoglu S., Okten A., Cakaloglu Y., et al. Hypogonadism is not related to the etiology of liver cirrhosis. J Gastroenterol 1995, 30:745-750.
9. Becker U., Almdal T., Christensen E., et al. Sex hormones in postmenopausal women with primary biliary cirrhosis. Hepatology 1991, 13:865-869.
10. Northup P.G., McMahon M.M., Ruhl A.P., et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006, 101:1524-1528.
11. Heit J.A., Silverstein M.D., Mohr D.N., et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Int Med 2000, 160:809-815.
12. Huerta C., Johansson S., Wallander M.A., et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Int Med 2007, 167:935-943.
13. Sogaard K.K., Horvath-Puho E., Gronbak H., et al. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009, 104:96-101.
14. Beemath A., Stein P.D., Skaf E., et al. Risk of venous thromboembolism in patients hospitalized with heart failure. Am J Cardiol 2006, 98:793-795.
15. Shetty R., Seddighzadeh A., Piazza G., et al. Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. J Thromb Thrombolysis 2008, 26:35-40.
16. Daneschvar H.L., Seddighzadeh A., Piazza G., et al. Deep vein thrombosis in patients with chronic kidney disease. Thromb Haemost 2008, 99:1035-1039.
17. Nguyen G.C., Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103:2272-2280.
18. Durand F., Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis 2008, 28:110-122.
19. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619.
20. Gulley D., Teal E., Suvannasankha A., et al. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci 2008, 53:3012-3017.
21. Anderson F.A., Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Int Med 1991, 151:933-938.
22. Silverstein M.D., Heit J.A., Mohr D.N., et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Int Medicine 1998, 158:585-593.
23. De Caterina M., Tarantino G., Farina C., et al. Haemostasis unbalance in Pugh-scored liver cirrhosis: characteristic changes of plasma levels of protein C versus protein S. Haemostasis 1993, 23:229-235.
24. Bell H., Odegaard O.R., Andersson T., et al. Protein C in patients with alcoholic cirrhosis and other liver diseases. J Hepatol 1992, 14:163-167.
25. Tofler G.H., Massaro J., Levy D., et al. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). Am J Cardiol 2005, 96:1280-1283.
26. Cohen H.J., Harris T., Pieper C.F. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003, 114:180-187.
27. Franchini M. Hemostasis and aging. Crit Rev Oncol Hematol 2006, 60:144-151.
28. Gharacholou S.M., Becker R.C. Hemostasis and thrombosis in older adults. J Thromb Thrombolysis 2009, 27:249-251.
29. White R.H., Dager W.E., Zhou H., et al. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 2006, 96:267-273.
30. White R.H., Zhou H., Murin S., et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005, 93:298-305.
31. White R.H., Zhou H., Romano P.S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998, 128(9):737-740.
32. White R.H., Keenan C.R. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009, 123(Suppl 4):S11-S17.
33. Bick R.L. Hereditary and acquired thrombophilic disorders. Clin Appl Thromb Hemost 2006, 12:125-135.
34. Christiansen S.C., Cannegieter S.C., Koster T., et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005, 293:2352-2361.
35. D'Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006, 44:217-231.
36. de Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005, 43:167-176.
37. Kramer J.R., Davila J.A., Miller E.D., et al. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther 2008, 27:274-282.
38. Grimes D.A., Schulz K.F. Bias and causal associations in observational research. Lancet 2002, 359:248-252.
39. Kanaan A.O., Silva M.A., Donovan J.L., et al. Meta-analysis of venous thromboembolism prophylaxis in medically ill patients. Clin Ther 2007, 29:2395-2405.
40. Leonardi M.J., McGory M.L., Ko C.Y. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg 2006, 141:790-797.